If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 11 - 20 of 279
Establishing an AI-based Foundation for Remote Automated Speech and Language Therapy in Aphasia
Objective
PIC NAME AI
Protocol No
NEURO-IIT-ANDERSON-PICNAMEAI
A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 3 Trial Evaluating the Efficacy and Safety of Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection (AMR) (TRANSCEND)
Objective
Felzartamab for the Treatment of Late Antibody-Mediated Rejection in Kidney Transplant Recipients
Protocol No
SURG-BIOGEN-TRANSCEND
Categories
The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (the "EMAGINE 2.0" Study)
Objective
Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment - EMAGINE 2.0
Protocol No
PMR-BRAINQ-EMAGINE-2
Categories
A Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7 + 3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients A
Objective
Testing the effects of novel therapeutics for newly diagnosed, untreated patients with acute myeloid leukemia
Protocol No
SWOG-MM1YA-S01
Categories
SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects With Moderately to Severely Active SLE
Objective
Oral Upadacitinib in Adults with Mild to Moderate SLE
Protocol No
RHEU-ABBVIE-SELECT-SLE
Categories
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema: The CONVERT II Trial
Objective
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema
Protocol No
PULM-PULMONX-CONVERT-II
Categories
A Multicenter Randomized Controlled Trial to Establish the Impact of MeMed BV® on Management of Patients with Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) (JUPITER TRIAL)
Objective
Management of LRTI in the ED and UCC - JUPITER
Protocol No
EM-MEMED-JUPITER
Categories
Symptom Monitoring Using Patient-Reported Outcomes To Optimize Medication Use
Objective
SyMPTOM Study
Protocol No
IIT-FLYNN-SYMPTOM
Categories
A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants with Relapsing Forms of Multiple Sclerosis (RMS) or Pr
Objective
Dose Escalation Study of CC-97540 in RMS or PM
Protocol No
NEURO-BMS-CA061-1006
Low Dose Naltrexone in the Treatment of Central Neuropathic Pain After Traumatic Spinal Cord Injury: A Pilot Study
Objective
Treating Central Neuropathic Pain With Low Dose Naltrexone for Spinal Cord Injury
Protocol No
PMR-IIT-CUI-LDN